TICKERNERD
Menu
ATECATECHealthcare · Medical Devices

ATEC Stock Forecast: Alphatec Holdings, Inc. Price Predictions for 2026-2027

Last close, 14 Oct 2026
$10
−3.51% on the day

The 14 Wall Street analysts covering Alphatec Holdings, Inc. hold a median 12-month price target of $15 — +43.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,600 US stocks, ranks it 74 of 100 as at 14 Oct 2026 — in the upper half. Here, the model and the Street point the same way.

Market cap
$1.7B
Ticker Nerd rank
74 / 100
Median analyst target
$15
Analysts covering
14
Revenue$213.5M+15.1% y/y
Operating income−$2.0M
Net income−$25.8M
Free cash flow−$1.6M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
+1.9%
1M
−3.9%
YTD
−50.4%
1Y
−24.4%
From 52W high
−54.0%
From 52W low
+49.4%
$7
$23
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

ATEC stock analysis: one number for the whole business

Consensus tells you what everyone already believes. The model scores Alphatec Holdings, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 14 Oct 2026
74 / 100

Percentile across ~4,600 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Quality
90
Growth
87
Accruals
80
Revisions
69
Value
68
Volatility
53
Size
38
Momentum
33
Issuance
25

Quality (90): The business earns solid, repeatable profits on what it owns.

Issuance (25): The company has been issuing shares or taking on financing, diluting existing holders.

Built and run by Aslam Ghouse, an ex-Goldman Sachs quant trader with fourteen years in markets.

Wall Street

ATEC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ATEC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$5$10$15$20$25Jan 26Apr 26Jul 26Oct 26ATECHigh $24Median $15Low $12

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says14 analysts
14 Buy0 Hold0 Sell
Low $12Median $15High $24

The green dot is the last close — the median target sits +43.7% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
5 Aug 2026BMO CapitalMaintainsOutperform$11 → $12
5 Aug 2026TD CowenMaintainsBuy$11 → $13
5 Aug 2026UBSMaintainsBuy$15 → $16
28 July 2026UBSInitiatesBuy$15
28 July 2026UBSInitiatesBuy—
23 July 2026Stephens & Co.InitiatesOverweight$15
23 July 2026Stephens & Co.InitiatesOverweight—
9 July 2026BMO CapitalInitiatesOutperform$11
9 July 2026BMO CapitalInitiatesOutperform—
8 July 2026StifelMaintainsBuy—
8 July 2026StifelMaintainsBuy$16 → $13
7 May 2026BarclaysMaintainsOverweight—
7 May 2026HC Wainwright & Co.ReiteratesBuy—
7 May 2026Wells FargoMaintainsOverweight—
6 May 2026Canaccord GenuityMaintainsBuy—
6 May 2026JP MorganMaintainsOverweight—
6 May 2026NeedhamMaintainsBuy—
6 May 2026Piper SandlerReiteratesOverweight—
6 May 2026TD CowenMaintainsBuy—
9 Mar 2026StifelMaintainsBuy—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Market Radar

This page is one stock. Monday covers all of them.

Computed off the Friday close and sent before the US open.

Market Radar reports the week’s largest rank changes across roughly 4,600 US stocks, the factor behind each one, and where the market went. ATEC appears on the weeks it earns a place.

Free, every Monday. Unsubscribe any time.

Performance

ATEC vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 14 Oct 2026, Alphatec Holdings, Inc. returned −24.4% against +17.5% for the S&P 500, dividends included.

ATEC vs S&P 500, last 12 monthsTotal return, rebased to 100
406080100120140160180Jan 26Apr 26Jul 26Oct 26ATECS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ATEC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingNext fiscal year
EPS revision, 90 days
+2.1%
Analysts raising
1
Analysts cutting
0
Fundamentals

Alphatec Holdings, Inc. (ATEC) financial data

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
−11.3×

Cheaper than 94% of US stocks

Price / sales
2.1×

Cheaper than 51% of US stocks

Price / book
−140.4×

Cheaper than 99% of US stocks

EV / EBITDA
58.6×

Cheaper than 4% of US stocks

Growth & margins
Revenue growth (YoY)
15.1%

Higher than 62% of US stocks

Earnings growth (YoY)
15.1%

Higher than 53% of US stocks

Gross margin
72.2%

Higher than 85% of US stocks

Operating margin
−0.9%

Higher than 31% of US stocks

Net margin
−13.5%

Higher than 18% of US stocks

Returns & dividend
Return on equity
−373.4%

Higher than 4% of US stocks

Return on assets
−3.1%

Higher than 35% of US stocks

Dividend yield
0.0%

Higher than 1% of US dividend payers

Bars mark the percentile across the ~4,600 US stocks Ticker Nerd covers, among those reporting the figure.

Key statistics

Alphatec Holdings, Inc. (ATEC) statistics: revenue, profit & scale

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Alphatec Holdings, Inc. has a market value of $1.7B and an enterprise value of $2.2B.

  • Revenue in the twelve months to 30 June 2026: $815.1M. The latest quarter grew 15.1% year on year.

  • Net income over the same four quarters: −$110.0M, a −13.5% net margin.

  • Diluted earnings per share, trailing twelve months: $−0.71.

  • Free cash flow in the twelve months to 30 June 2026: −$5.7M.

  • Shares outstanding: 154.5M.

  • Trailing P/E: −11.3×; forward P/E: 18.0× — the forward figure prices analyst consensus estimates, not reported earnings.

  • Forward dividend yield: 0.00%, paying out 0% of earnings.

  • Alphatec Holdings, Inc. employs 913 people — $893K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 13 Oct 2026

Data provided by Twelve Data

Peers

ATEC vs competitors

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelMedical Devices
CompanyMarket capTKN rank
ATECAlphatec Holdings, Inc.$1.7B
74
NVCRNovoCure Ltd.$1.6B
96
ESTAEstablishment Labs Holdings, Inc.$1.7B
74
ALMRAlamar Biosciences, Inc. (California)$1.7B
4
CNMDCONMED Corp.$1.4B
95
INSPInspire Medical Systems, Inc.$1.9B
87
AXGNAxogen, Inc.$2.1B
80

Look up any of the roughly 4,600 stocks we score.

The rank is the raw material. Whether the rules would actually own Alphatec Holdings, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

News

Latest ATEC news & analysis

ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy

Business Wire · 23 Sept 2026positive

Alphatec Holdings announced that Thomas "Tommy" Carls has joined the company as Executive Vice President of Data Intelligence and Strategy, a newly created role. Carls will report directly to Chairman and CEO Pat Miles and serve on ATEC's Senior Leadership Team.

Why it matters — The appointment signals ATEC's investment in data intelligence and strategic leadership, which could shape the company's future direction in spine surgery offerings.

Alphatec (ATEC) Moves 19.7% Higher: Will This Strength Last?

Zacks Investment Research · 14 Sept 2026neutral

Alphatec (ATEC) shares surged 19.7% in the last session on higher-than-average trading volume. According to Zacks, the latest trend in earnings estimate revisions may not translate into further price increases in the near term.

Why it matters — ATEC watchers would care because the sharp single-session move and the caution about earnings estimate revisions bear directly on whether the stock's recent strength can be sustained.

Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript

Seeking Alpha · 5 Aug 2026neutral

Alphatec Holdings, Inc. (ATEC) held its Q2 2026 earnings call, the transcript of which was published by Seeking Alpha.

Why it matters — For ATEC watchers, the earnings call transcript provides direct insight into the company's second-quarter performance and management's perspective on the business.

Alphatec (ATEC) Q2 Earnings Lag Estimates

Zacks Investment Research · 5 Aug 2026negative

Alphatec (ATEC) reported quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share in the same quarter a year ago.

Why it matters — The earnings came in below the consensus estimate, making it a notable data point for those tracking ATEC's quarterly financial performance.

Alphatec Q2 Earnings Call Highlights

MarketBeat · 4 Aug 2026positive

Alphatec reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier. Growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow.

Why it matters — ATEC watchers would care because the results point to accelerating procedure growth and surger adoption translating into stronger profitability and positive free cash flow.

FAQ

Frequently asked questions about ATEC stock

What is the ATEC stock price forecast for 2026-2027?

The 14 Wall Street analysts covering Alphatec Holdings, Inc. have a median 12-month price target of $15, with estimates ranging from $12 to $24. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ATEC stock a buy right now?

Of the 14 analysts covering Alphatec Holdings, Inc., 14 rate it a Buy, 0 a Hold and 0 a Sell. Ticker Nerd's systematic factor model ranks Alphatec Holdings, Inc. 74 out of 100 across roughly 4,600 US stocks as at 14 Oct 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ATEC?

As at 14 Oct 2026, Alphatec Holdings, Inc. ranks 74 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,600 US stocks, built from its factor families. Its strongest factor family is Quality (90 of 100).

Will ATEC stock go up?

No one can know that. What the data says: the median 12-month target from 14 analysts implies +43.7% from the last close, and Ticker Nerd's factor model ranks Alphatec Holdings, Inc. 74 out of 100 as at 14 Oct 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ATEC stock forecast for 2030?

No analyst covering Alphatec Holdings, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ATEC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $12 to $24 over the next 12 months.

How has ATEC stock performed over the past year?

Alphatec Holdings, Inc. returned -24.4% over the 12 months to 14 Oct 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Alphatec Holdings, Inc. do?

Alphatec Holdings, Inc. is a medical technology company focused on the surgical treatment of spinal disorders.

What is the latest news on ATEC?

The most recent item we track (Business Wire, 23 Sept 2026): "ATEC Appoints Tommy Carls Executive Vice President, Data Intelligence and Strategy". Alphatec Holdings announced that Thomas "Tommy" Carls has joined the company as Executive Vice President of Data Intelligence and Strategy, a newly created role. Carls will report directly to Chairman and CEO Pat Miles and serve on ATEC's Senior Leadership Team.

Company

About Alphatec Holdings, Inc.

Alphatec Holdings, Inc. is a medical technology company focused on the surgical treatment of spinal disorders. Alphatec Holdings, Inc. develops and commercializes a broad portfolio of spine-care products and procedural solutions, including spinal implants, fixation systems, access instruments, biologics, imaging systems, and neuromonitoring technologies. Its offerings are designed to support surgeons across the full workflow of spine procedures, from preoperative planning and intraoperative guidance to reconstruction and stabilization. The company’s product ecosystem includes the EOS imaging platform, SafeOp neural monitoring, and Valence navigation and robotics, alongside implant and biologics lines used in fusion and deformity procedures. Alphatec Holdings, Inc. serves hospitals, surgeons, and other healthcare providers in the United States and internationally, with a business centered on improving the precision, reproducibility, and clinical workflow of spine surgery.

CEO Mr. Patrick S. Miles · 913 employees · United States · https://www.atecspine.com